Selodenoson is under investigation in clinical trial NCT00040001 (Safety and Efficacy Study of an A1-adenosine Receptor Agonist to Slow Heart Rate in Atrial Fibrillation). The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Selodenosonum. Its PubChem CID is 3082555.
Selodenoson
| CAS No | 110299-05-3 |
|---|---|
| Molecular Formula | C17H24N6O4 |
| Molecular Weight | 376.4 g/mol |
| Synonyms | (2S,3S,4R,5R)-5-[6-(cyclopentylamino)purin-9-yl]-N-ethyl-3,4-dihydroxyoxolane-2-carboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Selodenoson is under investigation in clinical trial NCT00040001 (Safety and Efficacy Study of an A1-adenosine Receptor Agonist to Slow Heart Rate in Atrial Fibrillation).
The listed CAS number is 110299-05-3.
The listed molecular formula is C17H24N6O4.
The listed molecular weight is 376.4 g/mol.
(2S,3S,4R,5R)-5-[6-(cyclopentylamino)purin-9-yl]-N-ethyl-3,4-dihydroxyoxolane-2-carboxamide.
The source lists Selodenosonum.